1616385-51-3
1616385-51-3
Chemical Structure
Bezuclastinib
Synonym(s): CGT9486; PLX 9486
- CAS. Nr.: 1616385-51-3
- Formula:C19H17N5O
- Molecular Weight:331.37
IUPAC Name: 4,5-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazole-3-carboxamide
InChIKey: NVSHVYGIYPBTEZ-UHFFFAOYSA-N
SMILES: O=C(C1=NNC(C)=C1C)NC2=CN=C3NC(C4=CC=CC=C4)=CC3=C2
Biological Activity: Bezuclastinib (CGT9486) is an orally active, highly selective tyrosine kinase inhibitor with potent activity against KIT D816V. Bezuclastinib can be used for the research of nonadvanced systemic mastocytosis (NonAdvSM)[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bezuclastinib | 98.81% | Bezuclastinib (CGT9486) is an orally active, highly selective tyrosine kinase inhibitor with potent activity against KIT D816V. Bezuclastinib can be used for the research of nonadvanced systemic mastocytosis (NonAdvSM). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
